54 related articles for article (PubMed ID: 33837964)
1. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
[TBL] [Abstract][Full Text] [Related]
2. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
Momose H; Kurita N; Nishikii H; Yusa N; Yokoyama K; Shimizu E; Imoto S; Nanmoku T; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Matsuoka R; Obara N; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2024; 65(1):35-40. PubMed ID: 38311387
[TBL] [Abstract][Full Text] [Related]
3. AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function.
Braun T; Klepzig H; Herling M
Oncotarget; 2023 May; 14():395-397. PubMed ID: 37141408
[No Abstract] [Full Text] [Related]
4. Circulating Monocytes Phagocytosing Lymphocytes in the Small-Cell Variant of T-Cell Prolymphocytic Leukemia.
Zhang S; Ma M; Liu Y; Bu Y; Zhang Z; Zhang Y
Turk J Haematol; 2024 Mar; 41(1):53-54. PubMed ID: 38153214
[No Abstract] [Full Text] [Related]
5. Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database.
Wasifuddin M; Ilerhunmwuwa NP; Becerra H; Wang JC
Leuk Lymphoma; 2023 Dec; 64(12):2051-2053. PubMed ID: 37531079
[No Abstract] [Full Text] [Related]
6. T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.
Torabi A; Naresh KN
Blood; 2023 Jul; 142(1):119. PubMed ID: 37410504
[No Abstract] [Full Text] [Related]
7. T-cell prolymphocytic leukemia with lung involvement presenting as crazy paving on high-resolution computed tomography.
Drozd-Sokołowska J; Górska K; Król M; Hałaburda-Rola M; Wiktor-Jędrzejczak W; Jamroziak K
Pol Arch Intern Med; 2024 Apr; 134(4):. PubMed ID: 38449429
[No Abstract] [Full Text] [Related]
8. Livedoid thrombotic vasculopathy responding to doxycycline therapy.
Keller MS; Lee J; Webster GF
J Clin Aesthet Dermatol; 2008 Nov; 1(4):22-4. PubMed ID: 21212844
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban in the treatment of livedoid vasculopathy: A long-term retrospective study.
Deng S; Liu Y; Huang J; Shi W
JAAD Int; 2024 Mar; 14():36-38. PubMed ID: 38415054
[No Abstract] [Full Text] [Related]
10. Use of a spinal cord stimulator to treat livedoid vasculopathy: Effective control of an untreatable disease.
Revelles-Peñas L; Pastor-Navarro S; López-Piñero AA; Velasco-Tirado V
Actas Dermosifiliogr; 2024 Jan; ():. PubMed ID: 38056562
[No Abstract] [Full Text] [Related]
11. Refractory livedoid vasculopathy successfully treated with baricitinib.
Peñuelas Leal R; Grau Echevarría A; Martínez Domenech Á; Labrandero Hoyos C; Zaragoza Ninet V; Sanchez Carazo JL; Alegre de Miquel V
Int J Dermatol; 2023 Nov; 62(11):e608-e610. PubMed ID: 37306157
[No Abstract] [Full Text] [Related]
12. T-cell prolymphocytic leukemia, cerebriform variant.
Matos DM
Hematol Transfus Cell Ther; 2023 Feb; ():. PubMed ID: 36858855
[No Abstract] [Full Text] [Related]
13. Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and Treatment.
Robak E; Braun M; Robak T
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001655
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.
Leckey BD; Kheterpal MK; Selim MA; Al-Rohil RN
J Cutan Pathol; 2021 Jul; 48(7):975-979. PubMed ID: 33837964
[TBL] [Abstract][Full Text] [Related]
15. [A particular presentation of a T cell large granular lymphocytic leukaemia].
Donzel M; Bon Mardion M; Balme B
Ann Pathol; 2023 Jan; 43(1):52-56. PubMed ID: 36494259
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion.
Wasifuddin M; Sabzposh H; Sun L; Wu R; Wang JC
J Investig Med High Impact Case Rep; 2023; 11():23247096231176223. PubMed ID: 37219076
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Presentation of T-Cell Prolymphocytic Leukemia Mimicking Dermatomyositis.
Ingrasci G; Diaz-Perez J; Verne S; Romanelli P; Yosipovitch G
Am J Dermatopathol; 2021 Jul; 43(7):521-524. PubMed ID: 33606377
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous presentation of T-cell prolymphocytic leukemia.
Ventre MO; Bacelieri RE; Lazarchick J; Pollack RB; Metcalf JS
Cutis; 2013 Feb; 91(2):87-91. PubMed ID: 23513557
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
